These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 31375042)

  • 1. Glycemic Variability and Hypoglycemic Excursions With Continuous Glucose Monitoring Compared to Intermittently Scanned Continuous Glucose Monitoring in Adults With Highest Risk Type 1 Diabetes.
    Avari P; Moscardo V; Jugnee N; Oliver N; Reddy M
    J Diabetes Sci Technol; 2020 May; 14(3):567-574. PubMed ID: 31375042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
    Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
    Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching from Intermittently Scanned Continuous Glucose Monitoring to Real-Time Continuous Glucose Monitoring with a Predictive Urgent Low Soon Alert Reduces Exposure to Hypoglycemia.
    Preechasuk L; Avari P; Oliver N; Reddy M
    Diabetes Technol Ther; 2024 Jul; 26(7):498-502. PubMed ID: 38315504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    J Diabetes Sci Technol; 2024 May; 18(3):660-666. PubMed ID: 36172693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.
    Radovnická L; Hásková A; Do QD; Horová E; Navrátilová V; Mikeš O; Cihlář D; Parkin CG; Grunberger G; Prázný M; Šoupal J
    Diabetes Technol Ther; 2022 Dec; 24(12):859-867. PubMed ID: 36037056
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences for Percentage Times in Glycemic Range Between Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring in Adults with Type 1 Diabetes: Analysis of the REPLACE-BG Dataset.
    Avari P; Uduku C; George D; Herrero P; Reddy M; Oliver N
    Diabetes Technol Ther; 2020 Mar; 22(3):222-227. PubMed ID: 31613142
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
    Visser MM; Van Muylder A; Charleer S; Isitt JJ; Roze S; De Block C; Maes T; Vanhaverbeke G; Nobels F; Keymeulen B; Mathieu C; Luyten J; Gillard P; Verhaeghe N
    Diabetologia; 2024 Apr; 67(4):650-662. PubMed ID: 38236409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial.
    Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N
    Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Massa GG; Gys I; Bevilacqua E; Wijnands A; Zeevaert R
    Diabetes Res Clin Pract; 2019 Jun; 152():111-118. PubMed ID: 31121275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J; Petruželková L; Grunberger G; Hásková A; Flekač M; Matoulek M; Mikeš O; Pelcl T; Škrha J; Horová E; Škrha J; Parkin CG; Svačina Š; Prázný M
    Diabetes Care; 2020 Jan; 43(1):37-43. PubMed ID: 31530663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    Lancet; 2021 Jun; 397(10291):2275-2283. PubMed ID: 34089660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry.
    Sandig D; Grimsmann J; Reinauer C; Melmer A; Zimny S; Müller-Korbsch M; Forestier N; Zeyfang A; Bramlage P; Danne T; Meissner T; Holl RW
    Diabetes Technol Ther; 2020 Aug; 22(8):602-612. PubMed ID: 32522039
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial.
    Visser MM; Charleer S; Fieuws S; De Block C; Hilbrands R; Van Huffel L; Maes T; Vanhaverbeke G; Dirinck E; Myngheer N; Vercammen C; Nobels F; Keymeulen B; Mathieu C; Gillard P
    Lancet Diabetes Endocrinol; 2023 Feb; 11(2):96-108. PubMed ID: 36702566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia.
    Oliver N; Gimenez M; Calhoun P; Cohen N; Moscardo V; Hermanns N; Freckmann G; Reddy M; Heinemann L
    Diabetes Care; 2020 Jan; 43(1):53-58. PubMed ID: 31530662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus.
    Kovatchev B; Umpierrez G; DiGenio A; Zhou R; Inzucchi SE
    J Diabetes Sci Technol; 2015 Jun; 9(6):1227-35. PubMed ID: 26078255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
    Reddy M; Jugnee N; Anantharaja S; Oliver N
    Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of factors associated with improved glycemic control after switching from intermittently scanned to real-time continuous glucose monitoring in Japanese patients with type 1 diabetes.
    Yamada E; Nakajima Y; Horiguchi K; Okada S; Yamada M
    Endocr J; 2023 Dec; 70(12):1187-1193. PubMed ID: 37766568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions.
    Boscari F; Galasso S; Facchinetti A; Marescotti MC; Vallone V; Amato AML; Avogaro A; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):180-186. PubMed ID: 29258716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
    Crenier L
    Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among different glycemic variability indices obtained by continuous glucose monitoring.
    Saisho Y; Tanaka C; Tanaka K; Roberts R; Abe T; Tanaka M; Meguro S; Irie J; Kawai T; Itoh H
    Prim Care Diabetes; 2015 Aug; 9(4):290-6. PubMed ID: 25456706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.